SOPHARMA AD: Notification from Rompharm Company OOD

opublikowano: 2017-12-08 13:29

Spis treści:

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załącznikĂłw:
notification_113-rompharm.pdf (REPORT)

	POLISH FINANCIAL SUPERVISION AUTHORITY
				UNI - EN REPORT No		113	/	2017
	Date of issue:		2017-12-08
	Short name of the issuer
	SOPHARMA AD
	Subject
	Notification from Rompharm Company OOD
	Official market - legal basis
	art. 56. 1. 2 of Act on Public Offering.
	Unofficial market - legal basis
	Contents of the report:
	Sopharma AD notifies that on 8 December 2017 the Company received two notifications from Rompharm Company OOD for the sale of shares from the capital of Sopharma AD. The first notification concerns the sale of 5 000 000 shares, as a result of which the share of Rompharm Company OOD in the capital of Sopharma AD fell under 15% to 12.88%. The date of the registration of the transaction with the Central Depository is 7 December 2017. The first notification concerns the sale of 4 685 000 shares, as a result of which the share of Rompharm Company OOD in the capital of Sopharma AD fell under 10% to 9.41%. The date of the registration of the transaction with the Central Depository is 8 December 2017.
	Annexes
	File				Description
	notification 113-rompharm.pdfnotification 113-rompharm.pdf				Notification from Rompharm Company OOD

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification
of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

16

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

nd

(NIP)

(REGON)

	SIGNATURE OF PERSONS REPRESENTING THE COMPANY
	Date	Name	Position / Function	Signature
	2017-12-08	Ognian Donev	Executive director